Skip to main content

DINAMICA DE LA MAQUINARIA MOLECULAR SINAPTICA EN LOS PROCESOS COGNITIVOS Y EL DEFICIT INTELECTUAL.

BES-2013-063720

•
Funding agency name Ministerio de Ciencia e Innovación
Funding agency acronym MICINN
Program Programa Estatal de Promoción del Talento y su Empleabilidad en I+D+i
Subprogram Subprograma Estatal de Formación
Call Contratos Predoctorales
Call year 2013
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Secretaría de Estado de Educación, Formación Profesional y Universidades
Beneficiary centre INSTITUT DE RECERCA DE L HOSPITAL DE LA SANTA CREU I SANT PAU

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

Endogenous Syngap1 Alpha Splice Forms Promote Cognitive Function and Seizure Protection

  • Kilinc, Murat
  • Arora, Vineet
  • Creson, Thomas K.
  • Rojas, Camilo
  • Le, Aliza A.
  • Lauterborn, Julie
  • Wilkinson, Brent
  • Hartel, Nicolas
  • Graham, Nicholas
  • Reich, Adrian
  • Gou Alsina, Gemma|||0000-0001-7438-2417
  • Araki, Yoichi
  • Bayés, Àlex|||0000-0002-5265-6306
  • Coba, Marcelo P.
  • Lynch, Gary
  • Miller, Courtney A.
  • Rumbaugh, Gumbaugh
Loss-of-function variants in SYNGAP1 cause a developmental encephalopathy defined by cognitive impairment, autistic features, and epilepsy. SYNGAP1 splicing leads to expression of distinct functional protein isoforms. Splicing imparts multiple cellular functions of SynGAP proteins through coding of distinct C-terminal motifs. However, it remains unknown how these different splice sequences function in vivo to regulate neuronal function and behavior. Reduced expression of SynGAP-α1/2 C-terminal splice variants in mice caused severe phenotypes, including reduced survival, impaired learning, and reduced seizure latency. In contrast, upregulation of α1/2 expression improved learning and increased seizure latency. Mice expressing α1-specific mutations, which disrupted SynGAP cellular functions without altering protein expression, promoted seizure, disrupted synapse plasticity, and impaired learning. These findings demonstrate that endogenous SynGAP isoforms with α1/2 spliced sequences promote cognitive function and impart seizure protection. Regulation of SynGAP-α expression or function may be a viable therapeutic strategy to broadly improve cognitive function and mitigate seizure.